← Back to the boardNews
FDA warns against online weight-loss drugs containing uncertain ingredients
Why it’s here: An FDA warning letter and safety alerts on unapproved compounded semaglutide sold online are federal regulatory enforcement actions, though the topic is consumer health rather than transformational technology.
Trace across the boardItem
6d agoYahoo · research by Food and Drug AdministrationFDA warns against online weight-loss drugs containing uncertain ingredientsFDA issued a warning letter to Cheap Medicine Shop and a safety alert on dosing errors, cautioning consumers about unapproved online semaglutide weight-loss injections.1 outletBiotech6 linked
Connected
6 links- NewsSTAT+: FDA warns GLP-1 drugs carry potential risk of rare eye conditionBoth involve Food and Drug Administration
- NewsUS FDA orders new eye risk warnings for Ozempic, ZepboundBoth involve Food and Drug Administration
- HillComments due: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities: Discussion Paper and Request for FeedbackBoth involve Food and Drug Administration
- HillComments due: Robotically-Assisted Surgical Devices - Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Draft GuidanceBoth involve Food and Drug Administration
- NewsSTAT+: GLP-1s are given an FDA warning for rare eye condition riskBoth involve Food and Drug Administration
- HillComments due: Public Workshop: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation CapabilitiesBoth involve Food and Drug Administration
About
- Food and Drug Administration